Uncertainty in the Era of Precision Medicine.

The article discusses the uncertainty in precision medicine in terms of the outcomes of tailoring medical treatment and interpreting evidence on prognosis of cancer. It states that the era of precision medicine does not imply it can be certain that molecular mechanisms that therapeutic decisions should not be subject to adequately powered research trials. The study which examines the classified women to clinical and genomic risks of adjuvant chemotherapy is highlighted.